Letter
Angiotensin receptor blockers and myocardial infarction
Cite this as:
BMJ
2005;330:1270.2
Cautions voiced are biologically credible
- Zaheer R Yousef, specialist registrar (zypusef@dircon.co.uk),
- Francisco Leyva, consultant cardiologist,
- Christopher Gibbs, consultant cardiologist
- Department of Cardiology, Good Hope Hospital, Sutton Coldfield, West Midlands B75 7RR
Editor—We agree with Verma and Strauss that it is naive to consider that angiotensin receptor blockers are like angiotensin converting enzyme (ACE) inhibitors, but without the cough.1 Although the evidence is conflicting, the hypothesis that angiotensin receptor blockers may predispose to myocardial infarction when used in preference to ACE inhibitors warrants further attention.
Long term clinical benefits of …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012